Earlier last week the U.S. FDA had also shortened the time to receive a Pfizer booster shot from six months to five months for everyone 12 and older
JBI-802 is a novel, oral, potent and selective dual inhibitor of two epigenetic targets of the CoREST complex: LSD1 and HDAC6
BPZE1 is the most advanced next-generation pertussis vaccine currently in clinical development
Emergency Use Authorisation application request to be submitted following one month required by FDA EUA guidance
First emergency use authorization in the United States for a Covid-19 vaccine booster in adolescents 12 through 15 years of age
Rapid antigen testing provides results in just 15 minutes and the information can help reduce the risk of Covid-19 exposure
Adbry is the first biologic launched by LEO Pharma in the United States and is expected to be available in pharmacies by February 2022
The product is expected to be available in a week’s time
DCGI approved the drug based on the review of clinical data
The drug will be marketed under the brand name Molnaflu
Subscribe To Our Newsletter & Stay Updated
